Skip to main content
. Author manuscript; available in PMC: 2011 Apr 30.
Published in final edited form as: J Cardiovasc Pharmacol. 2010 Jan;55(1):14–20. doi: 10.1097/FJC.0b013e3181c5e743

Figure 4.

Figure 4

Histologic Changes. Representative left ventricular samples (LV) are shown in Panel A from Sham, Heart Failure (HF), and BNP-treated groups. BNP was associated with lower levels of LV infarction, as a percentage of total LV (Panel A) and reduced myocyte size after therapy (Panel B). (* p<0.05 vs. HF)